In our complimentary webcast, two of the industry's leading experts on laboratory commercialization, Rina Wolf and Lew Schuster, provide guidance on how early stage or emerging laboratories can distinguish themselves in a competitive funding environment. Do you know what you need to have in place to attract funding partners?
Understanding investors' issues with validation and adoptionDifferentiating your laboratory in a crowded funding environmentAnticipating and preparing for investor questionsRecognizing what investors should be asking, and developing a strategy to steer due diligence in the right direction
Responding to questions about your reimbursement strategies
In an environment where investment and innovation are being suppressed by a lack of clear regulatory or coverage paths, it is imperative for young labs to understand the current atmosphere. What are investors looking for, and what should they really be asking? What will you need to have to your pharmacoeconomic justification makes sense? What is the role of clinical utility? In one information-packed hour, we will cover the essentials for successful laboratory capitalization.
Vice President, Commercialization Strategies, Consulting & Industry Affairs